Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial

被引：0
|
作者：
João Pedro Ferreira
Cyrus Mehta
Abhinav Sharma
Steven E. Nissen
Patrick Rossignol
Faiez Zannad
机构：
[1] Université de Lorraine,Division of Cardiology
[2] Centre d’Investigations Cliniques Plurithématique Inserm 1433,Cleveland Clinic Coordinating Center for Clinical Research, Department of Cardiovascular Medicine
[3] Nancy,undefined
[4] France,undefined
[5] CHRU de Nancy,undefined
[6] Inserm U1116,undefined
[7] Nancy,undefined
[8] France,undefined
[9] FCRIN INI-CRCT,undefined
[10] INSERM U1116,undefined
[11] CHRU,undefined
[12] F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists),undefined
[13] Cytel Corportation,undefined
[14] Harvard T.H. Chan School of Public Health,undefined
[15] McGill University Health Centre,undefined
[16] McGill University,undefined
[17] Cleveland Clinic,undefined
来源：
BMC Medicine | / 18卷
关键词：
Alogliptin; Renal function; Stratification; Outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Alogliptin after acute coronary syndrome in patients with type 2 diabetes: a renal function stratified analysis of the EXAMINE trial
    Ferreira, Joao Pedro
    Mehta, Cyrus
    Sharma, Abhinav
    Nissen, Steven E.
    Rossignol, Patrick
    Zannad, Faiez
    BMC MEDICINE, 2020, 18 (01)
  • [2] Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
    White, William B.
    Cannon, Christopher P.
    Heller, Simon R.
    Nissen, Steven E.
    Bergenstal, Richard M.
    Bakris, George L.
    Perez, Alfonso T.
    Fleck, Penny R.
    Mehta, Cyrus R.
    Kupfer, Stuart
    Wilson, Craig
    Cushman, William C.
    Zannad, Faiez
    Aiub, Jorge
    Albisu, Juan
    Alvarez, Carlos
    Astesiano, Alfredo
    Barcudi, Raul
    Bendersky, Mario
    Bono, Julio
    Bustos, Betina
    Cartasegna, Luis
    Caruso, Orlando
    Casabe, Horacio
    Castro, Remo
    Colombo, Hugo
    Cuneo, Carlos
    Cura, Fernando
    De Loredo, Luis
    Dran, Ricardo
    Fernandez, Horacio
    Garcia Pinna, Jorge
    Hrabar, Adrian
    Klyver de Saleme, Maria
    Luquez, Hugo
    Mackinnon, Ignacio
    Maffei, Laura
    Majul, Claudio
    Mallagray, Marcelo
    Marino, Javier
    Martinez, Diego
    Martingano, Roberto
    Nul, Daniel
    Leonor Parody, Maria
    Petrucci, Jacqueline
    Pieroni, Mario
    Piskorz, Daniel
    Prado, Aldo
    Ramos, Hugo
    Resk, Jorge
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (14): : 1327 - 1335
  • [3] Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes
    Leitner, H.
    AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2014, 7 (02): : 77 - 77
  • [4] Renal Outcomes Associated with Alogliptin vs. Placebo in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndrome: Results from the EXAMINE Trial
    Vaduganathan, Muthiah
    White, William B.
    Charytan, David M.
    Wilson, Craig
    Kupfer, Stuart
    Lei, Lanyu
    Liu, Yuyin
    Zannad, Faiez
    Cannon, Christopher P.
    Bakris, George L.
    DIABETES, 2016, 65 : A316 - A316
  • [5] EXamination of CArdiovascular OutcoMes with AlogliptIN versus Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome (EXAMINE): A cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
    White, William B.
    Bakris, George L.
    Bergenstal, Richard M.
    Cannon, Christopher P.
    Cushman, William C.
    Fleck, Penny
    Heller, Simon
    Mehta, Cyrus
    Nissen, Steven E.
    Perez, Alfonso
    Wilson, Craig
    Zannad, Faiez
    AMERICAN HEART JOURNAL, 2011, 162 (04) : 620 - U70
  • [6] Total cardiovascular events analysis of the EXAMINE trial of patients with type 2 diabetes and recent acute coronary syndrome
    Cannon, C. P.
    Cavender, M. A.
    Liu, Y.
    Massaro, J. M.
    Bergenstal, R. M.
    Mehta, C. R.
    Zannad, F.
    White, W. B.
    DIABETOLOGIA, 2017, 60 : S530 - S531
  • [7] Total cardiovascular events analysis of the EXAMINE trial in patients with type 2 diabetes and recent acute coronary syndrome
    Cavender, Matthew A.
    White, William B.
    Liu, Yuyin
    Massaro, Joseph M.
    Bergenstal, Richard M.
    Mehta, Cyrus R.
    Zannad, Faiez
    Heller, Simon
    Cushman, William C.
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2018, 41 (08) : 1022 - 1027
  • [8] Impact of timing of randomization after an acute coronary syndrome and subsequent events in patients with type 2 diabetes mellitus: an analysis of the EXAMINE trial
    Elharram, M.
    Sharma, A.
    White, W.
    Bakris, G.
    Rossignol, P.
    Mehta, C.
    Ferreira, J.
    Zannad, F.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3067 - 3067
  • [9] Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial
    Ferreira, Joao Pedro
    Rossignol, Patrick
    Bakris, George
    Mehta, Cyrus
    White, William B.
    Zannad, Faiez
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [10] Body weight changes in patients with type 2 diabetes and a recent acute coronary syndrome: an analysis from the EXAMINE trial
    João Pedro Ferreira
    Patrick Rossignol
    George Bakris
    Cyrus Mehta
    William B. White
    Faiez Zannad
    Cardiovascular Diabetology, 20
12345